BMY FY 2013 Earnings — Bristol-Myers Squibb Company Revenue & Financial Results | Market Cap Arena

BMYBristol-Myers Squibb Company

$122B

FY 2013 Earnings

Healthcare Drug Manufacturers - General

Income Statement

Revenue

$16.4B-7.0% YoY

Gross Profit

$11.8B72.0% margin

Operating Income

$3.1B19.1% margin

Net Income

$2.6B15.6% margin

EPS (Diluted)

$1.54

Cash Flow

Operating Cash Flow

$3.5B

Free Cash Flow

$3.0B

Stock-Based Comp.

$191M

Balance Sheet

Total Assets

$38.6B

Total Liabilities

$23.4B

Stockholders' Equity

$15.2B

Cash & Equivalents

$3.6B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$16.4B	$17.6B	-7.0%
Gross Profit	$11.8B	$13.2B	-10.5%
Operating Income	$3.1B	$4.3B	-26.6%
Net Income	$2.6B	$2.0B	+30.8%